Becton, Dickinson and (BDX) Stock: Buy, Sell, or Hold?
BDX - Becton, Dickinson and Co.
$194.34
0.54 (0.28%)
▲
5d:
+2.89%
30d:
+6.2%
90d:
+27.04%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When BDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BDX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BDX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$207.03
Based on 4.7% avg growth
INTRINSIC VALUE TODAY
$128.55
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BDX is currently trading at $194.34, which is considered extended relative to its 30-day fair value range of $178.33 to $186.08. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.6) compared to its historical average (12.4). At these levels, the market is pricing in 5.5% annual earnings growth.
Technical Outlook: Technically, BDX is in a strong uptrend. The price is approaching resistance at $195.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BDX scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDX is in a strong uptrend. The price is approaching resistance at $195.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BDX scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$178.33 -
$186.08
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
Protect Your Profits
Holding BDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($194.08)
- BULLISH: Expecting earnings turnaround to 5.5% growth with 5.4% revenue growth
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$178.33 -
$186.08
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$178.90
Resistance Level
$195.99
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.61
Wall Street Target
$194.08
(-0.1%)
Revenue Growth (YoY)
5.4%
Earnings Growth (YoY)
-31.4%
Profit Margin
4.2%
Valuation Premium vs History
+5.5% premium
PE vs Historical
14.6 vs 12.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.5%
(market-implied from PE analysis)
1-Year Target
$205.03
(+6%)
2-Year Target
$216.31
(+11%)
3-Year Target
$228.20
(+17%)
3-Yr Target (if PE normalizes)
(PE: 15→12)
PE COMPRESSION
$193.69
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 5.3%)
$308.81
(+59%)
Base:
(SPY PE: 14.6, Growth: 5.3%)
$227.17
(+17%)
Bear:
(PE: 12.4, Growth: 5.3%)
$192.81
(-1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (44x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 44.35 | Current EPS (TTM): $4.37
Bull Case
$426.36
(+119%)
Analyst growth 100.0%, PE expands to 48.8
Base Case
$387.60
(+99%)
Market implied 100.0%, PE stable at 44.4
Bear Case
$131.78
(-32%)
Severe decline -20.0%, PE contracts to 37.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 21, 2026 8:44 PM ET
Data refreshes hourly during market hours. Next update: 9:44 PM
Data refreshes hourly during market hours. Next update: 9:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 41 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 45 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 53 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$413 | 37 SELL |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 67 BUY |
Advanced BDX Option Strategies
Professional options setups generated by AI based on today's BDX price and gamma walls.
